AEMD : Update On Doctor Mawanda

Nov 4, 2014 Featured: Home Page, MARKET 0 1140 Views

For those patiently watching Aethlon Medical and the results of its treatment of Dr. Michael Mawanda in Frankfurt, Germany, you will be pleased to know that according to an SMS Media report¬†from yesterday he is out of the isolation unit at Frankfurt University Hospital and is “expected to be back on duty very soon.”

This news comes on the heels of a press release the company put out entitled “Aethlon Medical Discloses Ebola Treatment Pathways In The United States.” That release details information on the company’s FDA plans and interactions and once again informs investors that the breadth of indications the Hemopurifier can help to treat is deep and wide. This is incredibly important in our view because this company is one we will be reading about long after the Ebola epidemic has been tamed.

We think the value proposition here is apparent and we expect a better reflection of value with increasingly sustained attention paid to the company once a formal release is issued by Frankfurt University Hospital on Dr. Mawanda’s condition and Aethlon is able to detail its participation.

As always, please do your own due diligence.

Share this on: Facebook // Twitter // Delicious // Digg // Reddit // Stumbleupon
Related Posts
AEMD: Launch of FDA Study & CTE Results Expected Soon

Feb 5, 2015

PLUG, AEMD, SIMH, HYSR: Four Predictions for 2015

Jan 6, 2015

Aethlon Medical: One Device – One Country – $1 Billion

Dec 4, 2014

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

@ Copyright 2014. EdvaDaily site by Atlanta Marketing Consultants